Saturday, July 11, 2026

pharma · Cervical Cancer · Non-small Cell Lung Cancer

Sichuan Baili Pharmaceutical

News and analysis for Sichuan Baili Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
4
Drugs
0
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Sichuan Baili Pharmaceutical — regulatory, clinical, and market coverage.

News and analysis for Sichuan Baili Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Sichuan Baili Pharmaceutical yet.

Back to company overview →